Visualizaciones | |
---|---|
Phase II study of Pazopanib to evaluate the activity and tolerability in patients with advanced and/or metastatic liposarcoma who have relapsed following therapies or for whom no standard therapy exists | 99 |
octubre 2023 | noviembre 2023 | diciembre 2023 | enero 2024 | febrero 2024 | marzo 2024 | abril 2024 | |
---|---|---|---|---|---|---|---|
Phase II study of Pazopanib to evaluate the activity and tolerability in patients with advanced and/or metastatic liposarcoma who have relapsed following therapies or for whom no standard therapy exists | 1 | 2 | 5 | 3 | 4 | 1 | 0 |
Visualizaciones | |
---|---|
MONSORIU - Estudio fase II de Pazopanib para evaluar la actividad y tolerancia en pacientes con l....pdf | 2 |
Visualizaciones | |
---|---|
Estados Unidos | 46 |
China | 16 |
Francia | 16 |
España | 11 |
Irlanda | 4 |
Argentina | 1 |
Alemania | 1 |
Corea del Sur | 1 |
Perú | 1 |
Singapur | 1 |
Visualizaciones | |
---|---|
Ashburn | 13 |
Grenoble | 9 |
Louisville | 7 |
Hangzhou | 6 |
Valencia | 5 |
Alameda | 4 |
Boardman | 4 |
Dublin | 4 |
Shenyang | 3 |
Villeurbanne | 3 |